Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for

Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Home > Insider Trading > Novo Nordisk A S > Profile

Novo Nordisk A S (NVO)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Fisher Asset Management

Ken Fisher

 13,463,144 $663,060 +6% 0.8%
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1.
Everett Harris & Co
 3,100,133 $152,682 4.22%
2.
Cim, Llc
 200,545 $9,877 3.83%
3.
Tirschwell & Loewy Inc
 405,995 $19,995 2.75%
4.
Alta Capital Management Llc
 842,314 $41,483 2.57%
5.
Jlb & Associates Inc
 145,220 $7,152 1.53%
News See All
30 Most Obese Countries In The World in 2018: Biggest Anti-Obesity Drug Markets

30 Most Obese Countries In The World in 2018: Biggest Anti-Obesity Drug Markets

The 30 most obese countries in the world in 2018 represent a huge (pun intended) market opportunity for weight loss drugmakers. Increasingly sedentary lifestyles and a lack of healthy eating habits among...... (read more)

March 22nd, 2018 - News - Comments

10 Least Obese Countries in the World

10 Least Obese Countries in the World

The 10 least obese countries in the world are mostly from Asia and Africa. Changing food habits, improving medical care and awareness about one’s health have contributed towards the betterment of public...... (read more)

March 26th, 2017 - Lists News - Comments

Here’s Our Take On The Global Blood Therapeutics Inc (GBT) Rumors

Here’s Our Take On The Global Blood Therapeutics Inc (GBT) Rumors

Global Blood Therapeutics Inc (NASDAQ:GBT) is spiking towards the end of the week on the suggestion that it might be an acquisition target for a big pharma name. The company will open the US session on...... (read more)

March 10th, 2017 - News Stock Analysis - Comments

11 Fattest Countries in The World

11 Fattest Countries in The World

The problem of obesity is a modern one, with large sections of the global population becoming overweight late in the 20th century and into the 21st, and the prevalence is especially high in the 11 fattest...... (read more)

January 17th, 2017 - Lists News - Comments

Sanofi SA (ADR) (SNY) Files Suit Against Novo Nordisk A/S (ADR) (NVO) Over False Insulin Claims

Sanofi SA (ADR) (SNY) Files Suit Against Novo Nordisk A/S (ADR) (NVO) Over False Insulin Claims

Novo Nordisk A/S (ADR) (NYSE:NVO) has been sued by Sanofi SA (ADR) (NYSE:SNY) for making false claims. In the lawsuit filed in the United States, the French company has accused Novo Nordisk of claiming...... (read more)

December 28th, 2016 - News Stock Analysis - Comments

10 Largest Hedge Funds in The World And Their Favorite Stock Picks

10 Largest Hedge Funds in The World And Their Favorite Stock Picks

Which are the largest hedge funds in the world? Most investors see hedge fund size as an indication of investment success. It is partially true though it is true that these hedge funds are extremely...... (read more)

December 8th, 2016 - Hedge Funds News - Comments

Novo Nordisk A/S (ADR) (NVO)Hedge Funds Are Snapping Up

Novo Nordisk A/S (ADR) (NVO)Hedge Funds Are Snapping Up

After several tireless days we have finished crunching the numbers from the more than 700 13F filings issued by the successful hedge funds and other investment firms that we track at Insider Monkey, which...... (read more)

December 5th, 2016 - Hedge Funds News - Comments

US FDA Approves Sanofi SA (ADR) (SNY) Soliqua 100/33, Novo Nordisk A/S (ADR) (NVO) Xultophy 100/3.6

US FDA Approves Sanofi SA (ADR) (SNY) Soliqua 100/33, Novo Nordisk A/S (ADR) (NVO) Xultophy 100/3.6

The US Food and Drug Administration (FDA) has recently approved the Soliqua 100/33 (insulin glargine and lixisenatide injection) of Sanofi SA (ADR) (NYSE:SNY) and the Xultophy 100/3.6 (insulin degludec...... (read more)

November 23rd, 2016 - News Stock Analysis - Comments

10 Most Successful Investors in the World

10 Most Successful Investors in the World

These 10 most successful investors in the world don’t have much in common aside from their obscene net worths. They come from different backgrounds, went to different schools, and use different strategies...... (read more)

November 2nd, 2016 - ETF Trading Hedge Funds Lists News - Comments

Novo Nordisk A/S (ADR) (NVO) Revisits New Strategy To Deal With U.S Payers

Novo Nordisk A/S (ADR) (NVO) Revisits New Strategy To Deal With U.S Payers

Novo Nordisk A/S (ADR) (NYSE:NVO) incoming President and CEO Lars Fruergaard Jørgensen is slated to start his leadership roles in the New Year. However, it seems he is raring to go given that he is already...... (read more)

November 1st, 2016 - News - Comments

Click here to See All News
Home Hedge Funds Markets Blog Authors About Us Contact Us Privacy Policy Terms of Use Site Map
All text and design is copyright ©2016 Koala Guide LLC. All rights reserved.